FindTrial
Sign In

Behavioural changes and usage of siddha prophylactic medicines during covid 19 in children

Assessment of behavioural changes and usage of siddha prophylactic medicines during the covid 19 pandemic in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040163
Enrollment
100
Registered
2022-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U07-U07- Provisional assignment of new diseases of uncertain etiology or emergency use Health Condition 2: J22- Unspecified acute lower respiratory infection

Interventions

None listed

Sponsors

National institute of siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with age group of 3-12years Both male and female children Parents of children who are willing to give informed consent.

Exclusion criteria

Exclusion criteria: Covid positive children Children with special care like autism affected children Mentally retarded children Any other serious illness

Design outcomes

Primary

MeasureTime frame
By this study ,the level of changes in behaviour and usage of siddha prophylactic medicine during the covid 19 pandemic in children.Timepoint: 6 months—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr G Subashini

National Institute of siddha

drarulmozhi2012@gmail.com9500151930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026